Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2005-2006 Formulation)

Trial Profile

Annual Study for Serum Collection and Evaluation of Safety and Immunogenicity Among Healthy Children Receiving Fluzone Influenza Virus Vaccine (2005-2006 Formulation)

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 27 Apr 2010 Official Title amended as reported by ClinicalTrials.gov.
    • 21 Sep 2008 Actual patient number (30) added as reported by ClinicalTrials.gov
    • 21 Sep 2008 Actual end date (1 Aug 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top